Matthew Hamilton Rosenberg’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$214K Sell
2,508
-20
-0.8% -$1.81K 0.04% 218
2026
Q2
$232K Buy
2,528
+745
+42% +$65.2K 0.04% 203
2026
Q1
$152K Buy
1,783
+215
+14% +$19.2K 0.03% 257
2025
Q4
$124K Buy
1,568
+705
+82% +$55.3K 0.03% 291
2025
Q3
$69K Sell
863
-2,247
-72% -$192K 0.01% 383
2025
Q2
$283K Buy
3,110
+1,380
+80% +$126K 0.07% 152
2025
Q1
$162K Buy
1,730
+5
+0.3% +$448 0.04% 215
2024
Q4
$157K Buy
1,725
+841
+95% +$80.3K 0.04% 223
2024
Q3
$91.8K Sell
884
-366
-29% -$37.3K 0.02% 336
2024
Q2
$119K Hold
1,250
– – 0.04% 259
2024
Q1
$111K Sell
1,250
-229
-15% -$19.4K 0.03% 292
2023
Q4
$118K Hold
1,479
– – 0.04% 272
2023
Q3
$105K Hold
1,479
– – 0.04% 271
2023
Q2
$114K Sell
1,479
-1,024
-41% -$79.3K 0.04% 267
2023
Q1
$188K Sell
2,503
-110
-4% -$8.18K 0.06% 195
2022
Q4
$206K Sell
2,613
-134
-5% -$10K 0.07% 172
2022
Q3
$193K Buy
2,747
+76
+3% +$5.96K 0.07% 166
2022
Q2
$219K Buy
2,671
+542
+25% +$42.4K 0.08% 155
2022
Q1
$161K Buy
2,129
+592
+39% +$46.9K 0.06% 227
2021
Q4
$131K Buy
1,537
+510
+50% +$39.8K 0.05% 256
2021
Q3
$78K Sell
1,027
-381
-27% -$30.3K 0.03% 322
2021
Q2
$115K Buy
1,408
+677
+93% +$55.4K 0.06% 239
2021
Q1
$58K Hold
731
– – 0.03% 328
2020
Q4
$63K Hold
731
– – 0.04% 298
2020
Q3
$56K Hold
731
– – 0.04% 293
2020
Q2
$54K Sell
731
-212
-22% -$15.1K 0.04% 293
2020
Q1
$63K Buy
+943
New +$66.5K 0.06% 221

Other funds holding CL

Matthew Hamilton Rosenberg's CL Position: Q3 2026 in Review

Matthew Hamilton Rosenberg reduced its Colgate-Palmolive (CL) stake by 0.79% in Q3 2026, selling an estimated $1.81K and leaving 2,508 shares worth $214K. The position accounts for 0.04% of the portfolio, ranked #218.

Matthew Hamilton Rosenberg first reported a position in CL in Q1 2020 and has held it in 27 quarters since. The position peaked at $283K in Q2 2025. 1,955 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Matthew Hamilton Rosenberg held 2,508 shares of Colgate-Palmolive worth $214K as of Q3 2026.
  • Matthew Hamilton Rosenberg sold 20 Colgate-Palmolive shares in Q3 2026, an estimated $1.81K.
  • Colgate-Palmolive made up 0.04% of Matthew Hamilton Rosenberg's portfolio in Q3 2026, its #218 holding.
  • Matthew Hamilton Rosenberg first reported a position in Colgate-Palmolive in Q1 2020 and has held it in 27 quarters since.
  • Matthew Hamilton Rosenberg's Colgate-Palmolive position peaked at $283K in Q2 2025.
  • 1,955 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q3 2026, filed 5 Oct 2026.